M&As this week: Betta Pharmaceuticals, Eli Lilly and Company
Chinese pharmaceutical company Betta Pharmaceuticals (Betta) has announced its intention to acquire a majority stake in fellow Chinese pharmaceutical company AnewPharma.
Chinese pharmaceutical company Betta Pharmaceuticals (Betta) has announced its intention to acquire a majority stake in fellow Chinese pharmaceutical company AnewPharma.
Betta proposes to pay ¥371.6m ($54.08m) to acquire 77.4% stake in the target company.
Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.
Excellence in Action Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.